Tamar Elkeles
About Tamar Elkeles
Dr. Tamar Elkeles, 56, has served as an independent director of The Glimpse Group (VRAR) since April 2024. She brings nearly 30 years of high-technology leadership, including as Chief Learning Officer at Qualcomm (1992–2015), with advanced academic credentials (M.S. and Ph.D. in Organizational Psychology). She currently chairs the Nominating & Corporate Governance Committee and serves on the Strategy Committee, reflecting governance expertise and board engagement .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Qualcomm | Chief Learning Officer | 1992–2015 | Led enterprise learning; deep HR/organizational expertise |
| Quixey, Inc. | Chief People Officer | 2015–2016 | Senior HR leadership in tech startup context |
| Atlantic Bridge Capital | Chief Talent Executive | 2016–2018 | Talent strategy for investment firm |
| XCOM Labs, Inc. | Chief Human Resources Officer | 2019–2021 | Built HR capabilities in advanced wireless startup |
External Roles
| Organization | Role | Status/Timing | Committees/Notes |
|---|---|---|---|
| GP Strategies Corporation | Director | Prior; until sale to Learning Technologies Group | Public company board experience |
| OpenSesame | Director | Current | Private company board |
| Forbes School of Business & Technology (Univ. of Arizona) | Board of Advisors | Current | Academic advisory role |
| Association for Talent Development | Board (previously), active member | Prior; active member now | Industry network roles |
Board Governance
- Committee roles: Chair, Nominating & Corporate Governance; Member, Strategy. Not on Audit or Compensation .
- Independence: Board affirmatively determined Elkeles is independent under Nasdaq standards; all members of Audit, Nominating & Governance, and Compensation committees are independent .
- Attendance: Board met 5 times in FY2025; no director attended fewer than 75% of Board/committee meetings. All directors except Elkeles and Ruckdaeschel attended the 2024 annual meeting of stockholders .
- Committee activity: Nominating & Corporate Governance held 1 meeting; Strategy held 9; Audit held 4; Compensation held 3 in FY2025, indicating active board oversight cadence .
- Board leadership: CEO also serves as Chair; the company does not have a Lead Independent Director (governance concentration risk) .
Fixed Compensation
Directors receive no cash compensation (only expense reimbursement); compensation is equity-based options under the company’s plan .
| Item | Amount / Terms | Notes |
|---|---|---|
| Annual cash retainer | $0 | No cash director pay disclosed |
| Committee chair/member fees | $0 | No cash fees disclosed; equity-only approach |
| FY2025 Option Awards (grant-date fair value) | $81,788 | Aggregate grant-date fair value for Elkeles |
| Options held as of June 30, 2025 | 57,500 options | Director-level holdings at FY2025 year-end |
| Initial appointment grant (2024) | 20,000 options | Vest monthly from Apr 29, 2024; strike $2.50 |
Performance Compensation
No performance metrics tied to director compensation are disclosed; director equity grants are service-vesting options under the company plan .
| Feature | Details |
|---|---|
| Performance metrics for director pay | None disclosed |
| Vesting (initial 2024 grant) | Options vest monthly from Apr 29, 2024 |
| Option terms (initial 2024 grant) | Strike $2.50 per share |
Related governance policies: The company has an SEC-compliant clawback policy (effective for awards on/after Oct 2, 2023) applicable to “Covered Executives,” with recovery of excess incentive compensation upon restatement; it defines applicable financial reporting measures, methods of recoupment, and non-indemnification. While focused on executives, it is a positive governance signal for pay-for-performance rigor .
Other Directorships & Interlocks
| Category | Disclosure |
|---|---|
| Related-party transactions (Item 404) | None disclosed for Elkeles at appointment; proxy reports “None” for related party transactions |
| Potential interlocks with VRAR stakeholders | Not disclosed; no related-party exposure indicated |
Expertise & Qualifications
- Organizational psychology expertise (M.S., Ph.D.) and decades of high-tech human capital leadership, including at Qualcomm .
- Governance expertise evidenced by chairing the Nominating & Corporate Governance Committee; involvement in strategy oversight .
- Prior public board experience (GP Strategies), private/academic board roles (OpenSesame, Forbes School) .
Equity Ownership
| Metric | Value | Notes |
|---|---|---|
| Common Stock Beneficially Owned | 54,375 shares | Includes options exercisable/vesting within 60 days |
| Ownership % of outstanding | 0.26% | Based on 21,076,506 shares outstanding at record date |
| Breakdown (footnote) | 48,125 fully vested options; 6,250 vest within 60 days | As per beneficial ownership footnote (8) |
| Shares pledged / hedging | Hedging disclosure section shows “None”; pledging not disclosed | Company’s “Employee, officer and director hedging” section shows “None” |
Governance Assessment
- Strengths: Independent status; chairs Nominating & Corporate Governance Committee; active Strategy Committee membership; board met regularly with committee activity; equity-only director pay aligns incentives to shareholder value creation .
- Alignment: Option-only compensation, initial grant vesting monthly, and beneficial ownership via exercisable options support alignment, though absolute ownership is modest (0.26%) typical for small-cap boards .
- Policies: Insider trading policy and clawback policy (for executives) reflect evolving governance controls; no related-party transactions for Elkeles reported .
- Watch items: Non-attendance at the 2024 annual meeting; combined CEO/Chair role with no Lead Independent Director concentrates authority—investors may monitor board independence and shareholder engagement practices .
RED FLAGS (to monitor)
- Missed 2024 annual meeting (attendance optics) .
- No Lead Independent Director (potential oversight imbalance) .